Lever
Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
Blutwerte · Marker
CD4/CD8-Ratio
T-Cell Ratio · T-Helfer/Suppressor-Ratio · CD4:CD8
Immunsystem
- Einheit:
- ratio
- Abbreviation
- CD4/CD8
The CD4/CD8 ratio quantifies the balance between CD4+ helper T cells and CD8+ cytotoxic T cells in the blood.
Reference Ranges
Reference
1–3.5ratio
1
1.5
2.5
3.5
LowNormalHigh
Reference
Optimal
Unit · ratioReference ranges may vary slightly between laboratories.
Overview
Übersicht
The CD4/CD8 ratio, also known as the T-cell ratio, measures the relative abundance of CD4+ helper T cells to CD8+ cytotoxic T cells in the blood. This ratio is a crucial indicator of immune system health, reflecting the balance between these two types of T cells that play distinct roles in immune response. Clinically, the CD4/CD8 ratio is significant in diagnosing and monitoring conditions like HIV/AIDS, where a low ratio indicates immune suppression and increased vulnerability to infections. It is also relevant in autoimmune diseases, certain cancers, and chronic infections, where deviations from the normal range can indicate disease progression or response to treatment. For athletes and biohackers, maintaining an optimal CD4/CD8 ratio is considered beneficial for immune resilience and recovery, though the direct impact on performance is less clear. Longevity research suggests that a balanced ratio may correlate with reduced inflammation and better health outcomes. However, the ratio can be influenced by factors such as acute infections, stress, and certain medications, which may confound interpretation. Time of day and fasting status generally do not significantly affect this marker, but consistent testing conditions are recommended for accurate monitoring.
Klinische Bedeutung
A low CD4/CD8 ratio is often associated with immune suppression, as seen in HIV/AIDS, and may indicate increased cancer risk. An elevated ratio can occur in autoimmune diseases and chronic infections.
Dynamics
Trend Interpretation
Rising Values
Progressively rising CD4/CD8 ratios may indicate improving immune function or response to treatment. Re-test in 3-6 months to confirm trend.
Falling Values
Progressively falling ratios may suggest worsening immune suppression or disease progression.
Re-test Interval
6 months if outside optimal range
Etiology
Causes — High & Low
Cause
Elevated Levels
- Autoimmune diseases
- Chronic infections
- Sarcoidosis
- Certain cancers
- Immunotherapy response
Cause
Low Levels
- HIV/AIDS
- Immunosuppressive therapy
- Chronic stress
- Viral infections
- Advanced age
Protocol
How to Optimize
Lever
Nutrition
- Balanced diet rich in fruits and vegetables
- Omega-3 fatty acids
- Probiotics
Lever
Supplementation
- Vitamin D
- Zinc
- Vitamin C
Note:
Consult a healthcare provider before starting any new supplement regimen.
Testing Guidelines
✓Fasting Not Required
✓Not Time-Sensitive
T-cell counts can vary throughout the day; morning tests are often recommended.
Testing Frequency
Annually for individuals with chronic conditions, more frequently if monitoring disease progression.
Interfering Factors
- Recent infections
- Immunosuppressive medications
- Acute stress
Open Research Questions
Current research suggests that reference ranges for the CD4/CD8 ratio in various populations, particularly in HIV-positive individuals, remain debated, with optimal targets for cancer risk prediction yet to be established. Researchers have not yet clarified the impact of confounding factors such as age, sex, and co-infections on this biomarker's predictive value. Additionally, clinical questions remain unanswered regarding the specific mechanisms by which the CD4/CD8 ratio influences cancer risk and its potential role in guiding immunotherapy responses.
23 Research Publications
206
Total Citations
17
Human/RCT
1.8
Avg. Influence
2025
Latest
Sort
Filter
01Top
#01
Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.
HumanInfluence3.0
57
This study focused on differentiating erythrodermic cutaneous T-cell lymphoma from atopic dermatitis. Researchers found that a high CD4/CD8 ratio in lesional skin was helpful in diagnosing erythrodermic cutaneous T-cell lymphoma, indicating its potential as a diagnostic marker.
02Top
#02
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
HumanInfluence3.0
22
Researchers found that a low CD4/CD8 ratio in people with HIV is associated with increased cancer risk, independent of CD4 cell count. This suggests that monitoring the CD4/CD8 ratio could serve as a clinical biomarker for cancer risk in this population.
03Top
#03
Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
Human
22
Researchers analyzed the prognostic role of peripheral blood T-cell subsets in triple-negative breast cancer (TNBC). They found that a higher CD4+/CD8+ ratio was associated with better treatment efficacy and longer progression-free and overall survival.
04
#04
Inflammatory mediators and lung abnormalities in HIV: A systematic review.
ReviewInfluence1.0
21
Researchers conducted a systematic review to assess the impact of inflammatory markers on lung function in individuals with HIV and pneumonia. They found that the CD4/CD8 ratio was associated with lung abnormalities, indicating its potential role as a biomarker in this population.
05
#05
Immunological Biomarkers of COVID-19.
Lei Rongwei & Mohan Chandra · Critical reviews in immunology · 2020
ReviewInfluence1.0
19
Researchers reviewed various hematological and inflammatory biomarkers associated with COVID-19, highlighting the importance of lymphocyte counts and ratios in assessing disease severity. They emphasized that multiplex biomarker analyses improve diagnostic accuracy compared to single biomarker evaluations.
Key findings
- 01Researchers observed significant changes in blood cell counts, such as lymphocytes and neutrophils, in COVID-19 patients.
- 02They identified key inflammatory markers, including interleukins and other proteins, that correlate with disease severity.
- 03The study highlighted that using a combination of biomarkers provides better diagnostic insights than relying on single markers alone.
06
#06
Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study.
Human
12
This pilot study investigated the predictive value of the CD4/CD8 lymphocyte ratio in gastric cancer patients undergoing neoadjuvant chemotherapy. Researchers found that a higher CD4+/CD8+ ratio significantly predicted a favorable treatment response.
07
#07
Role of CD4+T, CD8+T Cells, and CD4+T/CD8+T Cell Ratio in Gastric Cancer and Its Clinical Significance.
Human
9
Researchers found that the CD4/CD8 T-cell ratio and counts in gastric cancer patients correlate with tumor infiltration and may predict responses to immunotherapy. This underscores the potential of these immune markers in cancer prognosis.
08
#08
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.
Human
8
Researchers found that the abundance of a specific type of dendritic cell, linked to T and B cells, can predict progression-free survival in metastatic melanoma patients receiving immunotherapy. They also identified a correlation between this cell type and the CD8 T cell ratio, suggesting its potential as a biomarker for improving treatment responses.
09
#09
Beyond biopsy for neurosarcoidosis: A review of blood and CSF biomarkers.
Lackey Elijah, et al. · Journal of neuroimmunology · 2024
Review
8
Researchers identified several potential biomarkers, including the CD4/CD8 ratio, that could improve the diagnosis of neurosarcoidosis. However, they noted that these biomarkers are not yet established in clinical practice due to issues with specificity.
Key findings
- 01Current diagnostic methods for neurosarcoidosis often require invasive biopsies, which can lead to delays and misdiagnosis.
- 02Angiotensin-converting enzyme (ACE) is not a reliable biomarker for neurosarcoidosis despite its association with systemic sarcoidosis.
- 03New potential biomarkers, such as soluble interleukin-2 receptor (IL-2R) and others, may improve diagnostic accuracy but require further research.
10
#10
Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era.
Human
8
Researchers observed that individuals with low-level HIV viremia exhibited a lower CD4/CD8 ratio and increased T-cell activation and senescence. This suggests that low-level viremia may lead to impaired immune responses and increased risk of future health complications.
Publication Trend
Research publications about CD4/CD8-Ratio over time
10totalTrack your bloodwork in PepStack
Log lab results, track trends and optimize your biomarkers over time.
Legal Disclaimer
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer